Dr. Thon

CEO/CSO, Platelet BioGenesis

How the Hatch-Waxman Act of 1984 protects startups

An article on how this U.S. act allows biotech startups to use patented technology for the purposes of generating data for FDA approval without needing to take out costly licenses is now available at The Black Hole.

How the Hatch-Waxman Act of 1984 protects startups

Comments are closed.